Global End Stage Renal Disease Market Report (2022 to 2030) - Growing Prevalence of Diabetes and Hypertension is Driving Growth - ResearchAndMarkets.com
Retrieved on:
Tuesday, September 20, 2022
Health, Pharmaceutical, Dialysis, Incidence, COVID-19, Chronic kidney disease, Blood pressure, Kidney failure, Diet, Risk, ESRD, Chapter Three, Blood, Population, Growth, CKD, Fresenius Medical Care, Hypertension, Diabetes, Infection, Patient, USD, Kidney, Quality of life, CDC, National Association Medical Staff Services, Heart, Hospital, Mortality, Weight gain, Kidney bean, WAK, CAGR, Health insurance, Pharmaceutical industry
The global end stage renal disease market size is anticipated to reach USD 261.64 billion by 2030, registering a CAGR of 12.9% over the forecast period.
Key Points:
- The global end stage renal disease market size is anticipated to reach USD 261.64 billion by 2030, registering a CAGR of 12.9% over the forecast period.
- Chronic Kidney Disease (CKD) is one of the major causes of increasing kidney failure rates among patients.
- Technological advancements in the treatment of renal failure are another factor expediting the market growth for ESRD.
- End Stage Renal Disease Market Variables, Trends & Scope